Your browser doesn't support javascript.
loading
A phase III, multicenter, randomized study of olvimulogene nanivacirepvec followed by platinum-doublet chemotherapy and bevacizumab compared with platinum-doublet chemotherapy and bevacizumab in women with platinum-resistant/refractory ovarian cancer.
Holloway, Robert W; Thaker, Premal; Mendivil, Alberto A; Ahmad, Sarfraz; Al-Niaimi, Ahmed N; Barter, James; Beck, Tiffany; Chambers, Setsuko K; Coleman, Robert L; Crafton, Sarah M; Crane, Erin; Ramez, Eskander; Ghamande, Sharad; Graybill, Whitney; Herzog, Thomas; Indermaur, Megan Dr; John, Veena S; Landrum, Lisa; Lim, Peter C; Lucci, Joseph A; McHale, Michael; Monk, Bradley J; Moore, Kathleen Nadine; Morris, Robert; O'Malley, David M; Reid, Thomas J; Richardson, Debra; Rose, Peter G; Scalici, Jennifer M; Silasi, Dan-Arin; Tewari, Krishnansu; Wang, Edward W.
Afiliación
  • Holloway RW; AdventHealth Cancer Institute, Orlando, Florida, USA sarfraz.ahmad@AdventHealth.com robhollowaymd@gmail.com.
  • Thaker P; Obstetrics and Gynecology, Washington University in Saint Louis, Saint Louis, Missouri, USA.
  • Mendivil AA; Hoag Cancer Center, Newport Beach, California, USA.
  • Ahmad S; AdventHealth Cancer Institute, Orlando, Florida, USA sarfraz.ahmad@AdventHealth.com robhollowaymd@gmail.com.
  • Al-Niaimi AN; Banner MD Anderson Cancer Center, Gilbert, Arizona, USA.
  • Barter J; Holy Cross Hospital, Silver Spring, Maryland, USA.
  • Beck T; Hoag Cancer Center, Newport Beach, California, USA.
  • Chambers SK; University of Arizona Cancer Center, Tucson, Arizona, USA.
  • Coleman RL; US Oncology Network, The Woodlands, Texas, USA.
  • Crafton SM; West Penn Hospital, Allegheny Health Network, Pittsburgh, Pennsylvania, USA.
  • Crane E; Levine Cancer Institution, Atrium Health, Charlotte, North Carolina, USA.
  • Ramez E; Moores Cancer Center, University of California San Diego, La Jolla, California, USA.
  • Ghamande S; Augusta University Medical College of Georgia, Augusta, Georgia, USA.
  • Graybill W; Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina, USA.
  • Herzog T; Cancer Center, University of Cincinnati, Cincinnati, Ohio, USA.
  • Indermaur MD; Women's Cancer Associates, St Petersburg, Florida, USA.
  • John VS; Northwell Health Cancer Institute, Lake Success, New York, USA.
  • Landrum L; Indiana University Simon Comprehensive Cancer Center, Indianapolis, Indiana, USA.
  • Lim PC; Center of Hope, Reno, Nevada, USA.
  • Lucci JA; McGovern Medical School, University of Texas Health Sciences Center at Houston, Houston, Texas, USA.
  • McHale M; Obstetrics, Gynecology, and Reproductive Sciences, University of California San Diego, La Jolla, California, USA.
  • Monk BJ; University of Arizona and Creighton University School of Medicine, HonorHealth Research Institute, Phoenix, Arizona, USA.
  • Moore KN; Stephenson Cancer Center, University of Oklahoma, Oklahoma City, Oklahoma, USA.
  • Morris R; Karmanos Cancer Center, Detroit, Michigan, USA.
  • O'Malley DM; James Cancer Center, The Ohio State University, Columbus, Ohio, USA.
  • Reid TJ; Kettering Health, Kettering, Ohio, USA.
  • Richardson D; Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
  • Rose PG; Gynecology Oncology Desk A-81, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
  • Scalici JM; Mitchell Cancer Institute, University of South Alabama, Mobile, Alabama, USA.
  • Silasi DA; Mercy St Louis/Diavid C Pratt Cancer Center, St Louis, Missouri, USA.
  • Tewari K; Chao Family Comprehensive Cancer Center, University of California Irvine, Irvine, California, USA.
  • Wang EW; City of Hope, Duarte, California, USA.
Int J Gynecol Cancer ; 33(9): 1458-1463, 2023 09 04.
Article en En | MEDLINE | ID: mdl-37666539
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Vacunas Virales Tipo de estudio: Clinical_trials / Observational_studies Límite: Female / Humans Idioma: En Revista: Int J Gynecol Cancer Asunto de la revista: GINECOLOGIA / NEOPLASIAS Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Vacunas Virales Tipo de estudio: Clinical_trials / Observational_studies Límite: Female / Humans Idioma: En Revista: Int J Gynecol Cancer Asunto de la revista: GINECOLOGIA / NEOPLASIAS Año: 2023 Tipo del documento: Article